Clinical Trial Update: A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study of JNJ-77242113 in adults with moderate-to-severe plaque psoriasis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• JNJ-77242113

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2025-12-30